Trademark Overview
On Friday, January 19, 2024, a trademark application was filed for ENCRX with the United States Patent and Trademark Office. The USPTO has given the ENCRX trademark a serial number of 98366145. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, January 7, 2025. This trademark is owned by Encellin, Inc.. The ENCRX trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Pharmaceutical products for treatment of chronic diseases by means of gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for implantable cell therapy; living cells for gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for medical use, namely, encapsulated cells delivered by implantable cell therapy devices for secreting drugs and/or molecules; encapsulated pharmaceutical products for the treatment of chronic diseases; implantable pharmaceutical products for the treatment of chronic diseases; encapsulated pharmaceutical product for the treatment of chronic diseases delivered by implantable encapsulation devices with encapsulated cells for secreting drugs
Cell encapsulation devices in the nature of implantable drug and/or molecule and cell therapy delivery ports; implantable cell encapsulation devices in the nature of implantable drug and/or molecule and cell therapy delivery ports; implantable cell therapy devices in the nature of implantable drug and/or molecule and cell therapy delivery ports; drug and prescription encapsulation devices in the nature of implantable drug and cell therapy delivery ports; implantable drug and prescription encapsulation devices in the nature of implantable drug and cell therapy delivery ports; implantable drug and prescription delivery devices in the nature of implantable drug and cell therapy delivery ports
